160 related articles for article (PubMed ID: 20945941)
1. The regulation of factor IXa by supersulfated low molecular weight heparin.
Misenheimer TM; Sheehan JP
Biochemistry; 2010 Nov; 49(46):9997-10005. PubMed ID: 20945941
[TBL] [Abstract][Full Text] [Related]
2. The heparin-binding exosite is critical to allosteric activation of factor IXa in the intrinsic tenase complex: the role of arginine 165 and factor X.
Misenheimer TM; Buyue Y; Sheehan JP
Biochemistry; 2007 Jul; 46(26):7886-95. PubMed ID: 17563121
[TBL] [Abstract][Full Text] [Related]
3. The factor IXa heparin-binding exosite is a cofactor interactive site: mechanism for antithrombin-independent inhibition of intrinsic tenase by heparin.
Yuan QP; Walke EN; Sheehan JP
Biochemistry; 2005 Mar; 44(9):3615-25. PubMed ID: 15736971
[TBL] [Abstract][Full Text] [Related]
4. Heparin inhibits the intrinsic tenase complex by interacting with an exosite on factor IXa.
Sheehan JP; Kobbervig CE; Kirkpatrick HM
Biochemistry; 2003 Sep; 42(38):11316-25. PubMed ID: 14503882
[TBL] [Abstract][Full Text] [Related]
5. Depolymerized holothurian glycosaminoglycan and heparin inhibit the intrinsic tenase complex by a common antithrombin-independent mechanism.
Sheehan JP; Walke EN
Blood; 2006 May; 107(10):3876-82. PubMed ID: 16672689
[TBL] [Abstract][Full Text] [Related]
6. Low molecular weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: contribution of the serpin-independent mechanism.
Buyue Y; Misenheimer TM; Sheehan JP
J Thromb Haemost; 2012 Oct; 10(10):2086-98. PubMed ID: 22905983
[TBL] [Abstract][Full Text] [Related]
7. Selective disruption of heparin and antithrombin-mediated regulation of human factor IX.
Westmark PR; Tanratana P; Sheehan JP
J Thromb Haemost; 2015 Jun; 13(6):1053-63. PubMed ID: 25851619
[TBL] [Abstract][Full Text] [Related]
8. Phosphorothioate oligonucleotides inhibit the intrinsic tenase complex by an allosteric mechanism.
Sheehan JP; Phan TM
Biochemistry; 2001 Apr; 40(16):4980-9. PubMed ID: 11305914
[TBL] [Abstract][Full Text] [Related]
9. Fucosylated chondroitin sulfate inhibits plasma thrombin generation via targeting of the factor IXa heparin-binding exosite.
Buyue Y; Sheehan JP
Blood; 2009 Oct; 114(14):3092-100. PubMed ID: 19414859
[TBL] [Abstract][Full Text] [Related]
10. The heparin-binding exosite of factor IXa is a critical regulator of plasma thrombin generation and venous thrombosis.
Buyue Y; Whinna HC; Sheehan JP
Blood; 2008 Oct; 112(8):3234-41. PubMed ID: 18647957
[TBL] [Abstract][Full Text] [Related]
11. Conformational activation of antithrombin by heparin involves an altered exosite interaction with protease.
Izaguirre G; Aguila S; Qi L; Swanson R; Roth R; Rezaie AR; Gettins PG; Olson ST
J Biol Chem; 2014 Dec; 289(49):34049-64. PubMed ID: 25331949
[TBL] [Abstract][Full Text] [Related]
12. Interaction of factor IXa with factor VIIIa. Effects of protease domain Ca2+ binding site, proteolysis in the autolysis loop, phospholipid, and factor X.
Mathur A; Zhong D; Sabharwal AK; Smith KJ; Bajaj SP
J Biol Chem; 1997 Sep; 272(37):23418-26. PubMed ID: 9287357
[TBL] [Abstract][Full Text] [Related]
13. Factor IXa:factor VIIIa interaction. helix 330-338 of factor ixa interacts with residues 558-565 and spatially adjacent regions of the a2 subunit of factor VIIIa.
Bajaj SP; Schmidt AE; Mathur A; Padmanabhan K; Zhong D; Mastri M; Fay PJ
J Biol Chem; 2001 May; 276(19):16302-9. PubMed ID: 11278963
[TBL] [Abstract][Full Text] [Related]
14. Surface loop 199-204 in blood coagulation factor IX is a cofactor-dependent site involved in macromolecular substrate interaction.
Kolkman JA; Christophe OD; Lenting PJ; Mertens K
J Biol Chem; 1999 Oct; 274(41):29087-93. PubMed ID: 10506162
[TBL] [Abstract][Full Text] [Related]
15. Contribution of the NH2-terminal EGF-domain of factor IXa to the specificity of intrinsic tenase.
Qureshi SH; Yang L; Rezaie AR
Thromb Haemost; 2012 Dec; 108(6):1154-64. PubMed ID: 23014580
[TBL] [Abstract][Full Text] [Related]
16. Residues Tyr253 and Glu255 in strand 3 of beta-sheet C of antithrombin are key determinants of an exosite made accessible by heparin activation to promote rapid inhibition of factors Xa and IXa.
Izaguirre G; Olson ST
J Biol Chem; 2006 May; 281(19):13424-13432. PubMed ID: 16517611
[TBL] [Abstract][Full Text] [Related]
17. Structural integrity of the gamma-carboxyglutamic acid domain of human blood coagulation factor IXa Is required for its binding to cofactor VIIIa.
Larson PJ; Stanfield-Oakley SA; VanDusen WJ; Kasper CK; Smith KJ; Monroe DM; High KA
J Biol Chem; 1996 Feb; 271(7):3869-76. PubMed ID: 8632006
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulant Protein S Targets the Factor IXa Heparin-Binding Exosite to Prevent Thrombosis.
Plautz WE; Sekhar Pilli VS; Cooley BC; Chattopadhyay R; Westmark PR; Getz T; Paul D; Bergmeier W; Sheehan JP; Majumder R
Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):816-828. PubMed ID: 29419409
[TBL] [Abstract][Full Text] [Related]
19. The factor VIIIa C2 domain (residues 2228-2240) interacts with the factor IXa Gla domain in the factor Xase complex.
Soeda T; Nogami K; Nishiya K; Takeyama M; Ogiwara K; Sakata Y; Yoshioka A; Shima M
J Biol Chem; 2009 Feb; 284(6):3379-88. PubMed ID: 19047063
[TBL] [Abstract][Full Text] [Related]
20. Na+ site in blood coagulation factor IXa: effect on catalysis and factor VIIIa binding.
Schmidt AE; Stewart JE; Mathur A; Krishnaswamy S; Bajaj SP
J Mol Biol; 2005 Jul; 350(1):78-91. PubMed ID: 15913649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]